What an Interventionalist Needs to Know About MI with Non-obstructive Coronary Arteries [0.03%]
冠脉无阻塞性急性心梗的介入治疗需知事项
Robert Sykes,Daniel Doherty,Kenneth Mangion et al.
Robert Sykes et al.
MI with non-obstructive coronary arteries (MINOCA) is caused by a heterogeneous group of vascular or myocardial disorders. MINOCA occurs in 5.15% of patients presenting with acute ST-segment elevation MI or non-ST segment elevation MI and p...
Sveeta Badiani,Sanjeev Bhattacharyya,Nikoo Aziminia et al.
Sveeta Badiani et al.
Current guidelines recommend aortic valve replacement in patients with severe aortic stenosis in the presence of symptoms or a left ventricular ejection fraction
Ozan M Demir,Mhairi Bolland,Jonathan Curio et al.
Ozan M Demir et al.
Over the past decade, several transcatheter devices have been developed to address the treatment of severe mitral regurgitation (MR) in patients at high surgical risk, mainly aimed at repairing the native mitral valve (MV). MV repair device...
Contemporary Management of Isolated Ostial Side Branch Disease: An Evidence-based Approach to Medina 001 Bifurcations [0.03%]
当代孤立 ostial 侧支病变的治疗：基于证据的 Medina 001 分叉病变处理方法
Suleiman Suleiman,J J Coughlan,George Touma et al.
Suleiman Suleiman et al.
The optimal management of bifurcation lesions has received significant interest in recent years and remains a matter of debate among the interventional cardiology community. Bifurcation lesions are encountered in approximately 21% of percut...
Frailty Scores and Their Utility in Older Patients with Cardiovascular Disease [0.03%]
衰弱评分在心血管疾病老年患者中的应用价值
Kenneth Jordan Ng Cheong Chung,Chris Wilkinson,Murugapathy Veerasamy et al.
Kenneth Jordan Ng Cheong Chung et al.
The world's population is ageing, resulting in more people with frailty receiving treatment for cardiovascular disease (CVD). The emergence of novel interventions, such as transcatheter aortic valve implantation, has also increased the prop...
Shifting Paradigms and Financing a Revolution: Providing Transcatheter Valves in the Public Health System. A View from Aotearoa New Zealand [0.03%]
转换观念和融资革命：从奥特罗阿新西兰视角看公共医疗系统中的经导管瓣膜置换术
Cameron McAlister,David Smyth
Cameron McAlister
Extended Statement by the British Cardiovascular Intervention Society President Regarding Transcatheter Aortic Valve Implantation [0.03%]
英国心血管介入学会主席关于经导管主动脉瓣植入术的声明
Philip MacCarthy,Dave Smith,Douglas Muir et al.
Philip MacCarthy et al.
First-in-Human Use of the Next-generation ProtEmbo Cerebral Embolic Protection System During Transcatheter Aortic Valve-in-valve Implantation [0.03%]
新一代ProtEmbo脑保护装置在经导管主动脉瓣中瓣植入术中的首次人体应用
Dariusz Jagielak,Radoslaw Targonński,Dariusz Ciećwierz
Dariusz Jagielak
Cerebral embolic protection (CEP) devices aim to reduce the risk of periprocedural cerebrovascular events during transcatheter aortic valve implantation (TAVI). Here, the authors describe the first-in-human experience with the ProtEmbo Cere...
John G Coghlan,Alexander Mk Rothman,Stephen P Hoole
John G Coghlan
Balloon pulmonary angioplasty (BPA) is a novel technique for the treatment of chronic thromboembolic pulmonary hypertension. While cardiologists need no introduction to the concept of balloon angioplasty, BPA has its own particular challeng...